SGRY - Surgery Partners, Inc.
NEXT EARNINGS:
Mar 2, 2026
(in 6 days)
EPS Est: $0.31
|
Rev Est: $866.5M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$18.50
DETAILS
HIGH:
$19.00
LOW:
$18.00
MEDIAN:
$18.50
CONSENSUS:
$18.50
UPSIDE:
20.29%
Market Cap:
1.99B
Volume:
1,702,288
Avg Volume:
1,603,178
52 Week Range:
13.135-25.61
Sector:
Healthcare
Industry:
Medical - Care Facilities
Beta:
1.97
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
15,000
IPO Date:
2015-09-30
EPS (TTM):
-1.33
P/E Ratio:
-15.88
Revenue (TTM):
3.11B
Total Assets:
7.89B
Total Debt:
3.70B
Cash & Equiv:
269.50M
Rev Growth (5Y):
11.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
30.3%
ROCE:
4.8%
Debt/Equity:
2.07
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $0.13 | $0.19 | -31.6% | $821.5M | $866.5M | -5.2% |
| 2025-08-05 | $0.17 | $0.16 | +6.3% | $826.2M | $823.5M | +0.3% |
| 2025-05-12 | $0.04 | $0.08 | -50.0% | $776.0M | $777.1M | -0.1% |
| 2025-03-03 | $0.44 | $0.38 | +15.8% | $864.4M | $800.1M | +8.0% |
| 2024-11-12 | $0.19 | $0.25 | -24.0% | $770.4M | $829.0M | -7.1% |
| 2024-08-06 | $0.21 | $0.21 | 0.0% | $762.1M | $735.6M | +3.6% |
| 2024-05-07 | $0.10 | $0.07 | +42.9% | $717.4M | $698.0M | +2.8% |
| 2024-02-26 | $0.44 | $0.37 | +18.9% | $735.4M | $741.5M | -0.8% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.11B | 2.74B | 2.54B | 2.23B | 1.86B | 1.83B | 1.77B | 1.34B | 1.15B | 959.89M | 403.29M | 284.60M |
| Net Income | (168.10M) | (11.90M) | (54.60M) | (70.90M) | (116.10M) | (74.80M) | (205.71M) | (52.98M) | 9.45M | 1.43M | (65.90M) | (9.06M) |
| EPS | -1.33 | -0.09 | -0.59 | -1.12 | -3.19 | 0.95 | -4.28 | -1.09 | 0.20 | 0.04 | -1.37 | -0.19 |
| Total Assets | 7.89B | 6.88B | 6.68B | 6.12B | 5.41B | 5.02B | 4.68B | 4.62B | 2.30B | 2.11B | 1.86B | 474.70M |
| Total Debt | 3.70B | 3.06B | 2.93B | 3.29B | 3.20B | 2.90B | 2.48B | 2.19B | 1.50B | 1.31B | 1.41B | 427.40M |
| Cash & Equivalents | 269.50M | 195.90M | 282.90M | 389.90M | 317.90M | 92.70M | 184.31M | 174.91M | 69.70M | 57.93M | 74.92M | 13.03M |
| Operating Cash Flow | 300.10M | 293.80M | 158.80M | 87.10M | 246.90M | 129.50M | 144.60M | 120.94M | 125.24M | 84.48M | 21.95M | 49.08M |
| Free Cash Flow | 209.70M | 205.00M | 78.20M | 29.50M | 204.00M | 55.90M | 104.80M | 91.34M | 86.13M | 51.04M | 12.51M | 44.93M |
| FCF per Share | 1.66 | 1.63 | 0.85 | 0.41 | 4.18 | 1.16 | 2.18 | 1.88 | 1.79 | 1.42 | 0.26 | 0.93 |
| Book Value | 1.79B | 1.99B | 2.00B | 1.09B | 550.10M | 691.80M | 404.64M | 654.73M | 9.68M | (4.03M) | (264.08M) | (103.62M) |
| Cash & ST Investments | 269.50M | 195.90M | 282.90M | 389.90M | 317.90M | 92.70M | 184.31M | 174.91M | 69.70M | 57.93M | 74.92M | 13.03M |
| ROC Equity | -0.09 | -0.01 | -0.03 | -0.07 | -0.21 | -0.11 | -0.51 | -0.08 | 0.98 | N/A | N/A | N/A |